Product Reports Resources Pricing Login Book a demo

Apixio

Biotech & Life Sciences · San Mateo, United States · Founded 2009

The data science company for healthcare MoreLess

Apixio is a pioneering company in the healthcare analytics sector, leveraging advanced artificial intelligence (AI) and machine learning to transform how healthcare data is utilized. The company primarily serves health plans and healthcare providers, helping them to extract valuable insights from the vast amounts of clinical documents generated annually. This is crucial because, in the U.S. alone, 1.2 billion clinical documents are created each year, and much of this data remains untapped.

Apixio's platform uses AI to enhance coding and auditing processes, making them more efficient and accurate. Traditional methods of coding and auditing are manual and time-consuming, but Apixio's technology automates these tasks, allowing coders to focus on more complex projects. This not only improves the accuracy of coding but also speeds up the entire process, leading to better operational efficiency.

The company operates in the healthcare market, specifically focusing on risk adjustment and quality improvement. Risk adjustment is a method used by health plans to predict the health costs of their members and ensure they receive appropriate funding. By providing precise and actionable insights, Apixio helps its clients improve their risk adjustment programs, which in turn can lead to better patient care and optimized financial performance.

Apixio's business model is based on providing AI-driven analytic services. They make money by offering these services to health plans and providers, who pay for the ability to leverage Apixio's technology to improve their operations and care delivery. The company also offers demos to potential clients, showcasing how their platform can revolutionize healthcare data usage.

In summary, Apixio is at the forefront of healthcare analytics, using AI to unlock the potential of clinical data, thereby improving coding accuracy, operational efficiency, and patient care.

Keywords: AI, healthcare analytics, clinical data, coding, auditing, risk adjustment, machine learning, health plans, providers, operational efficiency.

Company overview

Apixio company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2009
Headquarters
San Mateo, United States
Employees
78
Open positions
None listed
Dealroom signal
61.9
Investment activity
1 companies · latest Jun 2023
Capital deployed
Preferred round
ACQUISITION
technologyArtificial Intelligenceclient focusb2ctechnologyDeep Techsub industryBioTechnologysub industryHealth Platformbusiness modelSaaSindustryHealthsectorRisk ManagementsectorBiotechnologysectorDrug DevelopmentsectorCore AIsectorTechbiosectorHard TechsectorAI Applications

Valuation & funding

Apixio funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
BUYOUTExit May 2023 $0 New Mountain Capital
ACQUISITIONExit Nov 2020 $0 Centene Corporation
SERIES DEquity / VC May 2016 $19M $77M First Analysis · Bain Capital Ventures · SSM Partners
SERIES CEquity / VC May 2014 $14M $54M Bain Capital Ventures · Farzad (Zod) Nazem
SERIES BEquity / VC Aug 2012 Undisclosed
SERIES AEquity / VC Mar 2011 Farzad (Zod) Nazem
SERIES AEquity / VC Dec 2009 Undisclosed
Showing 7 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 74
2025 107
2024 274
2023 203
2022 203
2021 180
2020 160
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Apixio website traffic

Latest recorded traffic for Apixio is 2.7K monthly website visits, up 50% over the last three months. Apixio's team declined 27.1% over the past year.

Latest monthly visits2.7K 3-month web change+50% 1-year team growth-27.1%
Monthly website visits118 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Apixio compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Apixio investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Apixio's talent

Book a demo to see the people
Team profiled 33 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Apixio's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Farzad (Zod) Nazem
Series B+ 4 investors entered at this stage
Bain Capital Ventures
SSM Partners
First Analysis
New Mountain Capital
Other known 2 additional known investors
Centene Corporation
RONAholdings

Global footprint

Where Apixio has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Apixio

Recent press, funding announcements, and product moves mentioning Apixio — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Apixio

An AI-synthesized read of the highest-engagement posts about Apixio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Apixio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.